Welcome to our dedicated page for KNOREX LTD. SEC filings (Ticker: KNRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The KNOREX Ltd. (NYSE American: KNRX) SEC filings page provides access to the company’s official regulatory disclosures as a foreign private issuer. KNOREX files with the U.S. Securities and Exchange Commission under file number 001-42862, and its submissions include documents that explain its financial condition, operations, and corporate developments.
Among the key filings are Form F-1, which KNOREX used in connection with its initial public offering of Class A ordinary shares, and recurring Form 6-K reports. The company has furnished unaudited condensed consolidated financial statements for periods such as the six months ended June 30, 2025, along with operating and financial reviews and accompanying press releases. These materials provide detail on revenue trends, business performance, and management’s discussion of results.
KNOREX’s filings also cover corporate governance and audit matters. In one Form 6-K, the company disclosed a change in its independent registered public accounting firm, describing the dismissal of its prior auditor, the appointment of a new auditor, and the prior auditor’s reports, which included an emphasis of going concern uncertainty. The filing further addressed the absence of reportable disagreements or reportable events as defined under SEC rules.
Through Stock Titan, users can view KNOREX’s SEC filings as they are made available on EDGAR, and benefit from AI-powered summaries that highlight the most important points in lengthy documents. This includes quick insights into interim financial statements, narrative reviews, and other exhibits. For investors researching KNRX, these filings offer a primary source of information on the company’s financial reporting, risk disclosures, and key corporate actions.
KNOREX Ltd. entered new financing arrangements that include issuing $3 million in senior unsecured notes and securing an equity purchase commitment of up to $50 million of class A ordinary shares. The notes mature in June 2026, generated net proceeds of $2.7 million, and part of the funds were used to repay existing debt.
Under a share purchase agreement, an investor may buy ordinary shares over 36 months after a resale registration statement becomes effective, at small discounts to market prices. KNOREX will also pay up to $500,000 in commitment fees in ordinary shares, mainly supporting future funding flexibility and general corporate purposes.
KNOREX LTD. chairman and CEO Choo Khar Heng filed an initial ownership report showing significant holdings in both voting shares and warrants. He directly owns 3,082,100 Class B Ordinary Shares, each convertible into one Class A Ordinary Share at any time with no expiration, and 342,450 Class A Ordinary Shares.
In addition, his mother holds 95,225 Class A Ordinary Shares and several warrant positions over Class A shares, including warrants over 14,175 and 45,800 shares at an exercise price of $2.074, 1,425 shares at $2.03, and 76,150-share tranches at $1.497 with different expirations. These warrants are exercisable only in the final three months of their term and are subject to anti-dilution adjustments. Choo Khar Heng disclaims beneficial ownership of securities held by his mother except to the extent of his pecuniary interest.
KNOREX LTD. officer KUMAR ABHISHEK filed an initial ownership report showing his equity stake in the company. He directly holds 243,450 Class B Ordinary Shares, which are convertible into an equal number of Class A Ordinary Shares at any time and have no expiration date.
He also directly holds 27,025 Class A Ordinary Shares. In addition, he holds warrants covering 6,350 Class A Ordinary Shares at an exercise price of $1.5000 per share. These warrants expire on January 28, 2027 and can only be exercised during the final three months of their term, with the underlying share count subject to adjustment for certain corporate actions.
KNOREX LTD. vice president of operations Le Truong Vinh Phu filed an initial statement of beneficial ownership. He directly holds 272,000 Class B Ordinary Shares, each convertible into one Class A Ordinary Share without expiration. He also owns 30,200 Class A Ordinary Shares and warrants over 5,100 Class A Ordinary Shares with a $2.03 exercise price, expiring on December 14, 2027. These warrants can only be exercised in the final three months of their term and are subject to adjustment for certain dilutive events.
KNOREX LTD. filed an initial insider ownership report for Chief Financial Officer Sun Ning. This Form 3 identifies Sun Ning as an officer of the company but does not list any reportable transactions or holdings in the non-derivative or derivative sections.
KNOREX LTD. director Chang Qi has filed an initial statement of beneficial ownership on Form 3. The provided data shows no reportable transactions, no derivative positions, and a neutral net buy/sell direction. This filing mainly establishes insider reporting status rather than reflecting any trading activity.
KNOREX LTD. director Jayant Kadambi filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting insider of the company and, in the information provided, does not list any stock transactions or option exercises.
VD Capital Pty Ltd reports beneficial ownership of 2,506,800 shares of Knorex Ltd. The Schedule 13G filing states 2,506,800 shares, representing 9.776% of the class, with sole voting and dispositive power over those shares as of 03/18/2026. The filing is signed by Zhi Qing Zhu, listed as a director.
KNOREX Ltd. reported that its Board of Directors has appointed Ning (Michael) Sun as Chief Financial Officer, effective January 22, 2026. The company says this move is intended to strengthen its executive team and financial leadership as it builds internal infrastructure for its next phase of growth as a public company.
Sun previously served as KNOREX’s Head of Capital Markets, overseeing capital markets planning, investor engagement, and pre-IPO initiatives. His background includes senior roles at U.S.-listed companies Jiayin Group and Fang Holdings, as well as earlier experience at Davis Polk & Wardwell LLP in Beijing.
KNOREX is a B2B technology company providing AI-driven, cross-channel programmatic advertising solutions through its KNOREX XPO platform, which helps marketers plan, execute, and optimize digital ad campaigns across multiple formats and channels.